Wu-Chou Su - JoVE Visualize

Showing results (171-180 of 258) with videos related to

Pageof 26

Sort By:

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2017

Dysregulation of Rab37-Mediated Cross-talk between Cancer Cells and Endothelial Cells via Thrombospondin-1 Promotes Tumor Neovasculature and MetastasisHong-Tai Tzeng, Chung-Han Tsai, Yi-Ting Yen, et al.

International Journal of Cancer|October 5, 2012

Circulating interleukin-6 level is a prognostic marker for survival in advanced nonsmall cell lung cancer patients treated with chemotherapyChin Hao Chang, Chin Fu Hsiao, Yu Min Yeh, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2022

Phase Ib Study of Telisotuzumab Vedotin in Combination With Erlotinib in Patients With c-Met Protein-Expressing Non-Small-Cell Lung CancerD Ross Camidge, Fabrice Barlesi, Jonathan W Goldman, et al.

Clinical Chemistry|September 19, 2023

Distinct Features of Plasma Ultrashort Single-Stranded Cell-Free DNA as Biomarkers for Lung Cancer DetectionJordan Cheng, Neeti Swarup, Feng Li, et al.

Investigational New Drugs|March 9, 2023

Evaluation of combination treatment with DS-1205c, an AXL kinase inhibitor, and osimertinib in metastatic or unresectable EGFR-mutant non-small cell lung cancer: results from a multicenter, open-label phase 1 studyJames Chih-Hsin Yang, Wu-Chou Su, Chao-Hua Chiu, et al.

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 29, 2019

Final Overall Survival and Other Efficacy and Safety Results From ASCEND-3: Phase II Study of Ceritinib in ALKi-Naive Patients With ALK-Rearranged NSCLCMakoto Nishio, Enriqueta Felip, Sergey Orlov, et al.

Journal of Nanobiotechnology|August 11, 2022

Iron oxide@chlorophyll clustered nanoparticles eliminate bladder cancer by photodynamic immunotherapy-initiated ferroptosis and immunostimulationYu-Cheng Chin, Li-Xing Yang, Fei-Ting Hsu, et al.

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 25, 2015

Estrogen Receptor Gene Polymorphisms and Lung Adenocarcinoma Risk in Never-Smoking WomenKuan-Yu Chen, Chin-Fu Hsiao, Gee-Chen Chang, et al.

Journal of the Formosan Medical Association = Taiwan Yi Zhi|February 26, 2020

Nivolumab safety and efficacy in advanced, platinum-resistant, non-small cell lung cancer, radical radiotherapy-ineligible patients: A phase II study in TaiwanYuh-Min Chen, James Chih-Hsin Yang, Wu-Chou Su, et al.

European Journal of Haematology|June 25, 2014

Long-term results of a phase II trial with frontline concurrent chemoradiotherapy followed by consolidation chemotherapy for localized nasal natural killer/T-cell lymphomaHui-Jen Tsai, Sheng-Fung Lin, Chu-Chih Chen, et al.

Pageof 26

Showing results (171-180 of 258) with videos related to

Sort By:

Pageof 26

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2017

Dysregulation of Rab37-Mediated Cross-talk between Cancer Cells and Endothelial Cells via Thrombospondin-1 Promotes Tumor Neovasculature and MetastasisHong-Tai Tzeng, Chung-Han Tsai, Yi-Ting Yen, et al.

International Journal of Cancer|October 5, 2012

Circulating interleukin-6 level is a prognostic marker for survival in advanced nonsmall cell lung cancer patients treated with chemotherapyChin Hao Chang, Chin Fu Hsiao, Yu Min Yeh, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2022

Phase Ib Study of Telisotuzumab Vedotin in Combination With Erlotinib in Patients With c-Met Protein-Expressing Non-Small-Cell Lung CancerD Ross Camidge, Fabrice Barlesi, Jonathan W Goldman, et al.

Clinical Chemistry|September 19, 2023

Distinct Features of Plasma Ultrashort Single-Stranded Cell-Free DNA as Biomarkers for Lung Cancer DetectionJordan Cheng, Neeti Swarup, Feng Li, et al.

Investigational New Drugs|March 9, 2023

Evaluation of combination treatment with DS-1205c, an AXL kinase inhibitor, and osimertinib in metastatic or unresectable EGFR-mutant non-small cell lung cancer: results from a multicenter, open-label phase 1 studyJames Chih-Hsin Yang, Wu-Chou Su, Chao-Hua Chiu, et al.

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 29, 2019

Final Overall Survival and Other Efficacy and Safety Results From ASCEND-3: Phase II Study of Ceritinib in ALKi-Naive Patients With ALK-Rearranged NSCLCMakoto Nishio, Enriqueta Felip, Sergey Orlov, et al.

Journal of Nanobiotechnology|August 11, 2022

Iron oxide@chlorophyll clustered nanoparticles eliminate bladder cancer by photodynamic immunotherapy-initiated ferroptosis and immunostimulationYu-Cheng Chin, Li-Xing Yang, Fei-Ting Hsu, et al.

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 25, 2015

Estrogen Receptor Gene Polymorphisms and Lung Adenocarcinoma Risk in Never-Smoking WomenKuan-Yu Chen, Chin-Fu Hsiao, Gee-Chen Chang, et al.

Journal of the Formosan Medical Association = Taiwan Yi Zhi|February 26, 2020

Nivolumab safety and efficacy in advanced, platinum-resistant, non-small cell lung cancer, radical radiotherapy-ineligible patients: A phase II study in TaiwanYuh-Min Chen, James Chih-Hsin Yang, Wu-Chou Su, et al.

European Journal of Haematology|June 25, 2014

Long-term results of a phase II trial with frontline concurrent chemoradiotherapy followed by consolidation chemotherapy for localized nasal natural killer/T-cell lymphomaHui-Jen Tsai, Sheng-Fung Lin, Chu-Chih Chen, et al.

Pageof 26